Titel	Veröffentlichungsdatum	Sprache	Zitate
Universal Health Coverage: A Quest for All Countries But under Threat in Some	2013/01/01	English	73
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure	2010/12/01	English	72
Economic Costs of Influenza-Related Work Absenteeism	2003/03/01	English	72
Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program	2010/12/01	English	72
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review	2019/10/01	English	72
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I	2010/01/01	English	72
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1]	2018/02/01	English	71
Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare Data	2008/03/01	English	71
Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries	2009/07/01	English	71
Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern Europe	2010/03/01	English	71
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA	2019/01/01	English	71
The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in the Health Outcomes Data Repository (HODaR): Descriptive Analysis from the First 20,000 Subjects	2005/09/01	English	70
An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study	2014/07/01	English	70
Costs of Care for Dementia Patients in Community Setting: An Analysis for Mild and Moderate Disease Stage	2011/09/01	English	70
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations	2007/11/01	English	70
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective	2016/09/01	English	70
Factors Influencing Cost-Related Nonadherence to Medication in Older Adults: A Conceptually Based Approach	2010/06/01	English	70
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective	2018/11/01	English	69
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group	2018/05/01	English	69
A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer	2011/09/01	English	69
Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group	2019/02/01	English	69
Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility	2007/05/01	English	69
Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures	2008/05/01	English	68
Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy	2012/03/01	English	68
Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?	2005/01/01	English	68
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group	2020/06/01	English	68
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes	2017/02/01	English	68
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom	2018/01/01	English	67
Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force	2017/03/01	English	67
A Review of the Cost of Atrial Fibrillation	2012/03/01	English	67